Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

EVALUATING T CELL DRIVEN IMMUNITY IN POST-VIRAL SYNDROMES

From Rugby Fields to Research Labs with Nigel McCracken (Spotify)

Nigel McCracken & Sean Knight – Research into T-Cell Exhaustion (with Jackie Baxter)

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Post-Viral Syndromes and the Utility of T cell Diagnostics

James Foster CEO & Nigel McCracken COO – Virax Biolabs (with Don Davis PhD)

Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

Identifying Post-Viral Syndromes Such as Long COVID

by John Parkinson

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Dr. Nigel McCracken, Ph.D. – Chief Operating Officer, Virax Biolabs